Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Jacot

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
Clinical Breast Cancer|January 2, 2018
Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast CancerAkiko Chiba, Rachna Raman, Alexandra Thomas, et al.
The Oncologist|August 19, 2018
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor BiologyGaia Griguolo, Stephane Pouderoux, Maria Vittoria Dieci, et al.
Breast Cancer Research and Treatment|July 8, 2017
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancersMarie Viala, Marie Alexandre, Simon Thezenas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 30, 2024
Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulationAlison Antoine, David Pérol, Mathieu Robain, et al.
BMC Cancer|February 1, 2019
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastasesAmélie Darlix, Christophe Hirtz, Simon Thezenas, et al.
BMC Cancer|November 7, 2013
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancerWilliam Jacot, Simon Thezenas, Romain Senal, et al.
International Journal of Cancer|June 6, 2022
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohortIvica Ratosa, Nika Dobnikar, Michele Bottosso, et al.
BMC Cancer|July 16, 2021
Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancerMarie Viala, Nelly Firmin, Célia Touraine, et al.
Breast (Edinburgh, Scotland)|March 28, 2025
Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2- early breast cancerWolfgang Janni, Michael Untch, Nadia Harbeck, et al.
Autoimmunity Reviews|October 31, 2021
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization databaseRadjiv Goulabchand, Nicolas Malafaye, William Jacot, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Clinical Breast Cancer|January 2, 2018
Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast CancerAkiko Chiba, Rachna Raman, Alexandra Thomas, et al.
The Oncologist|August 19, 2018
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor BiologyGaia Griguolo, Stephane Pouderoux, Maria Vittoria Dieci, et al.
Breast Cancer Research and Treatment|July 8, 2017
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancersMarie Viala, Marie Alexandre, Simon Thezenas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 30, 2024
Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulationAlison Antoine, David Pérol, Mathieu Robain, et al.
BMC Cancer|February 1, 2019
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastasesAmélie Darlix, Christophe Hirtz, Simon Thezenas, et al.
BMC Cancer|November 7, 2013
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancerWilliam Jacot, Simon Thezenas, Romain Senal, et al.
International Journal of Cancer|June 6, 2022
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohortIvica Ratosa, Nika Dobnikar, Michele Bottosso, et al.
BMC Cancer|July 16, 2021
Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancerMarie Viala, Nelly Firmin, Célia Touraine, et al.
Breast (Edinburgh, Scotland)|March 28, 2025
Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2- early breast cancerWolfgang Janni, Michael Untch, Nadia Harbeck, et al.
Autoimmunity Reviews|October 31, 2021
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization databaseRadjiv Goulabchand, Nicolas Malafaye, William Jacot, et al.
Pageof 20